Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01459770 · ClinicalTrials.gov registry record · NA
Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD
A NA study, sponsored by Providence Medical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01459770: Completed NA study, sponsored by Providence Medical Research Center.
NCT01459770 is a NA study that has completed, run by Providence Medical Research Center. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01459770, a NA study, has completed, sponsored by Providence Medical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Transitional care strategies focused on enhancing the accuracy and comprehensiveness of medication information transfer will lead to improved health outcomes among hospitalized patients with chronic kidney disease.
Primary Outcome
Acute care utilization defined by emergency department visits and hospitalizations in the first 30 and 90 days after discharge from the index hospitalization.
Interventions
- OTHER Medication Information Transfer Intervention
- OTHER Usual care for hospital discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT01459770 record still lists
NCT01459770 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Medication Information Transfer Intervention is the first listed.
NCT01459770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01459770 about?
NCT01459770 is a clinical study titled "Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD". Transitional care strategies focused on enhancing the accuracy and comprehensiveness of medication information transfer will lead to improved health outcomes among hospitalized patients with chronic kidney disease.
What is the current status of trial NCT01459770?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2011-11. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01459770?
The interventions under investigation include: Medication Information Transfer Intervention (OTHER), Usual care for hospital discharge (OTHER).
Who is sponsoring clinical trial NCT01459770?
This trial is sponsored by Providence Medical Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01459770's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia